Rangel A, Basave M, Lavalle C, Hernández L, Ochoa J, Chávez E, Albarrán H

Language: English
References: 16
Page: 66-71
PDF size: 295.68 Kb.

ABSTRACT

This is the case of a 27 years-old woman with signs and symptoms of severe untreatable congestive heart failure anemia, gingival mucosa ulcers, photosensitivity and alopecia. The electrocardiographic, echocardiographic, angiographic and hemodynamic data oriented the diagnosis of restrictive cardiomyopathy, mitral insufficiency secondary to mitral prolapse and bi-atrial dilation. The histologic study of the endomyocardial biopsy, performed during catheterization, showed signs of endomyocardial fibrosis, and immunological analysis was compatible with systemic lupus erythematosus. As far as we know, this is the first case of endomyocardial fibrosis (Davies disease) associated with systemic lupus erythematosus published in the medical literature. The etiology of Davies disease remains unrevealed and its association with systemic lupus erythematosus suggest a probable autoimmune origin.

REFERENCES

1. Davies JN: Endocardial fibrosis in Africans. East Afr Med J 1948; 25:10-16.

2. Bedford DE, Konstan GL: Heart failure of unknown aetiology in Africans. Br Heart J 1946; 8:236-240.

3. Goodwin JK: The frontiers of cardiomyopathy. Br Heart J 1982; 48:1-10.

4. Chew CY, Ziady GM, Nellen M, Oakley CM: Primary restrictive cardiomyopathy; no-tropical endomyocardial fibrosis and hypereosinophilic heart disease. Br Heart J 1997; 39:399-401.

5. Contreras R, Bialostozky D, Medrano G, Fishleder, Guadalajara J: Fibrosis endomiocárdica africana o tropical, comunicación del primer caso observado en México. Arch Inst Cardiol Méx 1971; 41:476-489.

6. Brockinton IF, Eckahardt GJ: Löefflers endocarditis and Davies endomyocardial fibrosis. Am Heart J 1973; 85:308-312.

7. Armenio AC, Esteves JP, Filho AS, Vanise M: Clinical aspects of endomyocardial fibrosis in Bahia Brazil. Am Heart J 1971; 81:7-19.

8. Williams AW, Ball JD, Davies JN: Endomyocardial fibrosis in Africa: its diagnosis, distribution and nature. Trans Roy Soc Med Hyg 1954; 48:290-294.

9. Siegel RJ, Prediman KS, Fisbein MC: Idiopathic restrictive cardiomyophaty. Circulation 1984; 70:165-169.

10. Wynne J, Braunwald E: The Cardiomyopathy and Myocarditis: Toxic, chemical and physical damage to the heart. In Heart Disease. Ed. E. Braunwald. Philadelphia. WB Saunders, 1992; 1421-1429.

11. Becker BJ, Chatgidakis CB, Van Linger B: Cardiovascular collagenosis with parietal endocardical thrombosis. A clinicopathologic study of 40 cases. Circulation 1953; 7:345-349.

12. Davies JN: The pathology of endomyocardial fibrosis in Uganda. Br Heart J 1955; 17:337-339.

13. Cotran R, Kumar V, Robbins S: Systemic lupus erythematosus. In: Robbins Pathologic Basis of Disease. 4th Ed. Philadelphia WB Saunders Co. 1989; 193-204.

14. Baandrup V: Löefflers endocarditis and endomyocardial fibrosis: a nosologic entity. Acta Pathol Miocrobiol Scand 1977; 85:869-872.

15. Westwood M: Heredity in primary endocardial fibroeleastosis. Br Heart J 1975; 35:1077-1079.

16. Rangel A, Lavalle C, Chávez E, Jiménez M, Acosta JL, Albarrán H: Myocardial infarction in patients with systemic lupus erythematosus with normal coronariography and without coronary vasculitis. Angiology 1999; 50:245-253.